Status:

COMPLETED

Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.

Lead Sponsor:

Emory University

Collaborating Sponsors:

HealthWatchSystems, Inc.

Conditions:

Infertility

Anovulation

Eligibility:

FEMALE

21-42 years

Brief Summary

The purpose of this study is to evaluate the effectiveness of the OV-Watch to predict ovulation while women are taking clomiphene citrate.

Detailed Description

At any given time, there are 10-15% of American couples with infertility. A problem with ovulation (releasing an egg) is one of the most common causes of female infertility. The frequency and timing o...

Eligibility Criteria

Inclusion

  • Patients eligible to participate must be between the age of 21 and 42.
  • Patient must demonstrate ability to follow standard clomiphene citrate ovulation induction protocol and wear the OV-Watch™ correctly.
  • Intact uterus and at least one ovary must be present.
  • Patients must be diagnosed with anovulation (lack of ovulation) that is not caused by hypothalamic amenorrhea or premature ovarian failure.
  • A hysterosalpingogram must be performed to demonstrate at least one patent fallopian tube. The uterine cavity must also appear normal on this study.
  • The male partner or sperm donor must demonstrate an acceptable concentration and motility of sperm.

Exclusion

  • 12 or more previous treatment cycles using clomiphene citrate.
  • Any condition where the use of clomiphene is contraindicated, such as breast cancer or liver disease.
  • Any other hormonal disease that may be secondarily causing anovulation, such as thyroid disorder or hyperprolactinemia.
  • Amenorrhea caused by premature ovarian failure or hypothalamic amenorrhea.
  • Any active genital tract infection will need to be treated with antibiotics before undergoing ovulation induction.

Key Trial Info

Start Date :

October 1 2005

Trial Type :

OBSERVATIONAL

End Date :

June 1 2007

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00239603

Start Date

October 1 2005

End Date

June 1 2007

Last Update

April 17 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory Reproductive Center, Crawford Long Hospital

Atlanta, Georgia, United States, 30308

Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate. | DecenTrialz